Proudly presenting: *Don't Just Read the Abstract* Our podcast, hosted by @PipNicolson and @richardbuka critiquing recent non-malig haem trials. #1 The PACER trial - platelets and CVC transfusion with study author + Prof. Simon Stanworth. On all platforms. Please share!

Really fantastic to be able to share this interview that has been a long time coming! @PipNicolson and I had a wonderful opportunity to catch up with @BritSocHaem President Dr Sue Pavord on everything she has been doing with BSH + some extra nuggets including #VITT

Our next Breakfast Briefing webinar in collaboration with thelimbusUK is this Thursday, 25th September at 8.15am. Dr Martin Besser will be discussing Crizanlizumab with our regional lead for Severn region, Dr Amy Cooper. Sign up here: https://t.co/67MaZ66irI

Our ISTH Legacy Fund is still open for travel grant applications. If you're hoping to attend an educational event then do consider applying. Please check the website for eligibility and further details about what's on offer. https://t.co/3Ugt30Me3t

@richardbuka @PipNicolson @bhwords

To improve care, we need (A) more real world data (trials very difficult in this population), standardised training, and broader, more equitable access to advanced therapies and PERTs.

Clinician confidence varies: 70% deem thrombolysis appropriate for high‑risk PE in pregnancy - but only 20% for intermediate risk. catheter-directed thrombolysis and thrombectomy perceived as useful mainly in high‑risk cases; uncertainty persists in many decisions.

Access to Pulmonary Embolism Response Teams (PERTs) is also inconsistent - 27% have them (often only during limited hours), 47% have none, and nearly 1 in 5 clinicians don’t even know if their hospital has one.

While most centers have access to advanced treatments - 81% for catheter‑directed thrombolysis (CDT), 74% for ECMO, and 67% for surgical thrombectomy - local guidelines & training are patchy: only 1/2 had CDT‑specific protocols, and a mere 28% had training in pregnancy‑related PE

The involving 70 clinicians across the UK & Ireland (Jan–Mar 2024) reveals major gaps in managing pulmonary embolism (PE) during pregnancy. Most respondents were experienced specialists (87% >10 years).

Led by @GiuliaSimini1, we recently conducted a UK-wide survey looking at management of high risk PE in pregnancy. This is now published in @e_JHaem. The work sets the scene for our on-going MaTRON project, collecting real-world data. Here's what the survey found. A short🧵

Access to Pulmonary Embolism Response Teams (PERTs) is also inconsistent - 27% have them (often only during limited hours), 47% have none, and nearly 1 in 5 clinicians don’t even know if their hospital has one.

While most centers have access to advanced treatments - 81% for catheter‑directed thrombolysis (CDT), 74% for ECMO, and 67% for surgical thrombectomy - local guidelines & training are patchy: only 1/2 had CDT‑specific protocols, and a mere 28% had training in pregnancy‑related PE

The involving 70 clinicians across the UK & Ireland (Jan–Mar 2024) reveals major gaps in managing pulmonary embolism (PE) during pregnancy. Most respondents were experienced specialists (87% >10 years).

🎧What's it like to be one of two haematologists in an entire West African country? 🌍 On the latest episode of Don't Just Read the Abstract, @PipNicolson and I discuss with Dr Megan Kell, Chair of the @BritSocHaem Global Specialist Interest Group about her time in the Gambia. 🩸

This month’s @HaemSTAR_UK blog is by the brilliant @GiuliaSimini1. Thank you for sharing your thoughts and the beautiful photo of the Haem-Obs @BritSocHaem team https://t.co/AkX2rUcuJF

Going to @BritSocHaem 2025? Listen to our preview of the conference, with a focus on non-malignant haematology. On all podcast platforms. With @richardbuka and @PipNicolson.

Now up on all podcast platforms! @PipNicolson and I review the programme for non-malignant haematology at @BritSocHaem 2025. Some great speakers but lots of horrible clashes. We'll be set up and recording at the @HaemSTAR_UK stand. Come say hi & you might end up on the show!

As Easter approaches, it’s a good time to recap on some of the most important / interesting studies in non-malignant / classical / medical haematology in 2025. A short🧵

Tomorrow! 08.15 - 09.00am Saskia Middledorp will deliver the HaemSTAR-Limbic webinar. We have a record number of people signed up to watch this live. Join us and ask your questions at the end of the talk. https://t.co/XElBrUc3CY

A reminder that HaemSTAR can offer travel grants to support trainees and allied health professionals to attend meetings and conferences etc. Our next review of applications is in June. See our website for details: